Abstract 1023: CD73 inhibition with a novel orally bioavailable small molecule blocks adenosine production and rescues T-cells activation
Year: 2020
Type: conference-abstract
Source: Cancer Research
Institution: ORIC Pharmaceuticals, Inc. (United States)
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3083172039
